TrialCancer chemotherapy and pharmacology2015

Alliance A091103 a phase II study of the angiopoietin 1 and 2 peptibody trebananib for the treatment of angiosarcoma.

Sandra P D' Angelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.